Controlled release of vancomycin from cross-linked gelatine

Abstract

This paper explores the possibility of using biodegradable cross-linked gelatines as antibiotic devices for a long-term elution (80 days). Capillary electrophoresis (CE) has been utilized to evaluate the mass percentage of vancomycin and gelatine contemporary released from differently cross-linked vancomycin loaded gelatine samples in an elution time ranging from 24 to 1920 h. While the solubilization kinetic of gelatine samples differently cross-linked can be very close described by the simplified Higuchi model, the vancomycin release kinetic is contemporary governed by both the Fickian diffusion process trough the gelatine matrix network and the dissolution process of the matrix due to its degradation. Comparing the antibiotic eluting kinetics from gelatine at diverse cross-linking degree we observed that the degradation of the proteic matrix appears to have a minor influence in the drug release control. Vancomycin released from all the gelatine partially cross-linked samples results active against Staphylococcus aureus and Streptococcus faecalis which represent the most pathogens commonly isolated in orthopaedic infections. Vancomycin overcomes the minimum inhibitory concentration for both the bacteria in the whole range of elution time. Cross-linked gelatine devices appear to represent a useful biodegradable delivery system for local anti-infective therapy in arthoplasty.

New PMMA-based composites for preparing spacer devices in prosthetic infections

“…The use of PMMA cements as antibiotic delivery devices is a widely used practice in orthopedics and has shown to be effective in the prevention and treatment of infection in both one-stage and two-stage revisions [37,38]. Moreover, many surgeons started adding antibiotics manually to the cements before polymerization during surgical procedures.…”

Biomimetic Nanostructured Apatitic Matrices for Drug Delivery

“…During the past three decades, however, complex formulations that control the rate and period of drug delivery (i.e., time-release medications) and that target specific areas of the body for treatment have become increasingly common. A controlled-release drug delivery system should be able to achieve the following benefits: (i) maintenance of optimum therapeutic drug concentration in the blood with minimum fluctuation, (ii) predictable and reproducible release rates for extended duration, (iii) enhancement of activity duration for short half-life drugs, (iv) elimination of side effects, frequent dosing, and wastage of drug, and (v) optimized therapy and improved patient compliance [93][94][95].…”

SiO2-CaO-P2O5 Bioactive Glasses: A Promising Curcuminoids Delivery System

“…, antibiotics and antitumoral medicaments) and/or growth factors, attract increasing attention since they can protect against infections but also regulate cell growth and enhance bone regeneration [2,3,4,5,6,7,8,9]. Basically, bone scaffolds should be biocompatible, biodegradable, osteoconductive and, in improved scaffold designs, they should be able to act as local drug carrier [2,9,10,11,12,13,14]. Scaffolds are usually made from tailored combination of inorganic and organic phases, forming composite structures aiming at replicate the structure and composition of bone tissue [2,3,13,15].…”